Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 3
2006 5
2007 2
2008 6
2009 1
2010 6
2011 3
2012 5
2013 6
2014 8
2015 7
2016 10
2017 3
2019 1
2020 3
2021 1
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 24510952

64 results
Results by year
Filters applied: . Clear all
Page 1
Demographic and treatment variability of refractory kawasaki disease: a multicenter analysis from 2005 to 2009.
Ghelani SJ, Pastor W, Parikh K. Ghelani SJ, et al. Hosp Pediatr. 2012 Apr 1;2(2):71-6. doi: 10.1542/hpeds.2011-00112. Hosp Pediatr. 2012. PMID: 24510952 Free article.
A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment.
Johnson SC, Williams DC, Brinton D, Chew M, Simpson A, Andrews AL. Johnson SC, et al. Hosp Pediatr. 2021 Jan;11(1):88-93. doi: 10.1542/hpeds.2020-0188. Epub 2020 Dec 8. Hosp Pediatr. 2021. PMID: 33293266
Kawasaki disease: a comprehensive review of treatment options.
Patel RM, Shulman ST. Patel RM, et al. J Clin Pharm Ther. 2015 Dec;40(6):620-5. doi: 10.1111/jcpt.12334. Epub 2015 Nov 7. J Clin Pharm Ther. 2015. PMID: 26547265 Review.
Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M. Ogata S, et al. Pediatrics. 2012 Jan;129(1):e17-23. doi: 10.1542/peds.2011-0148. Epub 2011 Dec 5. Pediatrics. 2012. PMID: 22144699 Clinical Trial.
Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database.
Moffett BS, Syblik D, Denfield S, Altman C, Tejtel-Sexson K. Moffett BS, et al. Pediatr Cardiol. 2015 Feb;36(2):374-8. doi: 10.1007/s00246-014-1016-1. Epub 2014 Sep 2. Pediatr Cardiol. 2015. PMID: 25179461
Kawasaki disease in Sicily: clinical description and markers of disease severity.
Maggio MC, Corsello G, Prinzi E, Cimaz R. Maggio MC, et al. Ital J Pediatr. 2016 Nov 2;42(1):92. doi: 10.1186/s13052-016-0306-z. Ital J Pediatr. 2016. PMID: 27806720 Free PMC article.
Factors Associated With Resource Utilization and Coronary Artery Dilation in Refractory Kawasaki Disease (from the Pediatric Health Information System Database).
Lo JY, Minich LL, Tani LY, Wilkes J, Ding Q, Menon SC. Lo JY, et al. Am J Cardiol. 2016 Dec 1;118(11):1636-1640. doi: 10.1016/j.amjcard.2016.08.039. Epub 2016 Aug 31. Am J Cardiol. 2016. PMID: 27665207
Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y. Furukawa T, et al. Arch Dis Child. 2008 Feb;93(2):142-6. doi: 10.1136/adc.2007.126144. Epub 2007 Oct 25. Arch Dis Child. 2008. PMID: 17962370
Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant Kawasaki disease: a prospective study.
Teraguchi M, Ogino H, Yoshimura K, Taniuchi S, Kino M, Okazaki H, Kaneko K. Teraguchi M, et al. Pediatr Cardiol. 2013 Apr;34(4):959-63. doi: 10.1007/s00246-012-0589-9. Epub 2012 Nov 27. Pediatr Cardiol. 2013. PMID: 23184018
Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
Sittiwangkul R, Pongprot Y, Silvilairat S, Phornphutkul C. Sittiwangkul R, et al. Singapore Med J. 2006 Sep;47(9):780-4. Singapore Med J. 2006. PMID: 16924360 Free article.
64 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback